Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies and Vaccines
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Info For
    • Manuscript Submission
      • 1-Minute Consult
      • Commentary
      • Current Drug Therapy
      • Editorial
      • Guidelines to Practice
      • Interpreting Key Trials
      • Letter to the Editor
      • Review
      • Smart Testing
      • Symptoms to Diagnosis
      • The Clinical Picture
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • Multimedia
    • Sponsored Videos
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • COVID-19
    • Curbside Consults Overview
    • Pulmonary/ICU
    • Patient Subsets & Specific Organ Involvement
    • Therapies and Vaccines
    • Imaging & Procedures
    • Patients with Underlying Disease
    • Virus Background & Testing
    • Healthcare System Practice
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
  • Multimedia
    • Sponsored Videos
  • Conference Coverage
    • ASH Annual Meeting
    • AHA Sessions 2020
    • IDWeek 2020
    • CHEST 2020
    • ADA 2020
    • ACC 2020
  • Advertise
    • Media Kit
    • Contact
Editorial

Renal denervation: Are we on the right path?

Ali E. Denktas, MD, FACC, FSCAI, David Paniagua, MD, FACC, FSCAI and Hani Jneid, MD, FACC, FAHA, FSCAI
Cleveland Clinic Journal of Medicine September 2017, 84 (9) 687-689; DOI: https://doi.org/10.3949/ccjm.84a.17024
Ali E. Denktas
Associate Professor of Medicine, Division of Cardiology, Baylor College of Medicine
Director of Cardiac Catheterization Laboratories, Michael E. DeBakey VA Medical Center, Houston, TX
site Principal Investigator for the SYMPLICITY HTN-3 Trial
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ali.denktas@bcm.edu
David Paniagua
Associate Professor of Medicine, Division of Cardiology, Baylor College of Medicine
Director of Structural Heart Disease Interventions, Michael E. DeBakey VA Medical Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hani Jneid
Associate Professor of Medicine and Director of Interventional Cardiology Research, Baylor College of Medicine
Director of Interventional Cardiology, Michael E. DeBakey VA Medical Center, Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

You do not have access to the full text of this article, the first page of the PDF of this article appears above.

REFERENCES

  1. ↵
    1. Bhatt DL,
    2. Kandzari DE,
    3. O’Neill WW,
    4. et al
    5. SYMPLICITY HTN-3 Investigators
    . A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370:1393–1401.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Shishehbor MH,
    2. Hammad TA,
    3. Thomas G
    . Renal denervation: what happened, and why? Cleve Clin J Med 2017; 84:681–686.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Kearney PM,
    2. Whelton M,
    3. Reynolds K,
    4. Whelton PK,
    5. He J
    . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217–223.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Kearney PM,
    2. Whelton M,
    3. Reynolds K,
    4. Whelton PK,
    5. He J
    . Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11–19.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Calhoun DA,
    2. Jones D,
    3. Textor S,
    4. et al
    5. American Heart Association Professional Education Committee
    . Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117:e510–e526.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Tsioufis C,
    2. Papademetriou V,
    3. Thomopoulos C,
    4. Stefanadis C
    . Renal denervation for sleep apnea and resistant hypertension: alternative or complementary to effective continuous positive airway pressure treatment? Hypertension 2011; 58:e191–e192.
    OpenUrl
  7. ↵
    1. Calhoun DA,
    2. Jones D,
    3. Textor S,
    4. et al
    . Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:140–1419.
    OpenUrl
  8. ↵
    1. Persell SD
    . Prevalence of resistant hypertension in the United States, 2003-2008. Hypertension 2011; 57:1076–1080.
    OpenUrlCrossRef
  9. ↵
    1. Papademetriou V,
    2. Doumas M,
    3. Tsioufis K
    . Renal sympathetic denervation for the treatment of difficult-to-control or resistant hypertension. Int J Hypertens 2011; 2011:196518.
    OpenUrlPubMed
  10. ↵
    1. Doumas M,
    2. Faselis C,
    3. Papademetriou V
    . Renal sympathetic denervation in hypertension. Curr Opin Nephrol Hypertens 2011; 20:647653.
    OpenUrl
  11. ↵
    1. Veterans Administration Cooperative Study Group on Antihypertensive Agents
    . Effect of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202:1028–1034.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Lewington S,
    2. Clarke R,
    3. Qizilbash N,
    4. Peto R,
    5. Collins R,
    6. Prospective Studies Collaboration
    . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903–1913.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Henegar JR,
    2. Zhang Y,
    3. Hata C,
    4. Narciso I,
    5. Hall ME,
    6. Hall JE
    . Catheter- based radiofrequency renal denervation: location effects on renal norepinephrine. Am J Hypertens 2015; 28:909–914.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Azizi M,
    2. Sapoval M,
    3. Gosse P,
    4. et al
    5. Renal Denervation for Hypertension (DENERHTN) investigators
    . Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 2015; 385:19571965.
    OpenUrl
  15. ↵
    1. Rosa J,
    2. Widimsky P,
    3. Waldauf P,
    4. et al
    . Role of adding spironolactone and renal denervation in true resistant hypertension: one-year outcomes of randomized PRAGUE-15 study. Hypertension 2016; 67:397–403.
    OpenUrl
  16. ↵
    1. Mahfoud F,
    2. Bohm M,
    3. Azizi M,
    4. et al
    . Proceedings from the European Clinical Consensus Conference for Renal Denervation: Considerations on Future Clinical Trial Design. Eur Heart J 2015; 6:2219–2227.
    OpenUrl

This article requires you to have a ccjm.org account to view the full text. If you already have an account, you may log in below to view this article along with all other CCJM content. If you do not have an account, register here. It’s free!

Log in using your username and password

Forgot your user name or password?
PreviousNext
Back to top

Registration is Now Required for Free Access to CCJM Content

Register once and log in for full access to articles and content. Click “Register” in the upper right corner and follow the simple instructions to create a new account.

If you are using a mobile device, click on the settings icon to access the Register link.

In this issue

Cleveland Clinic Journal of Medicine: 84 (9)
Cleveland Clinic Journal of Medicine
Vol. 84, Issue 9
1 Sep 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Renal denervation: Are we on the right path?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
12 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Renal denervation: Are we on the right path?
Ali E. Denktas, David Paniagua, Hani Jneid
Cleveland Clinic Journal of Medicine Sep 2017, 84 (9) 687-689; DOI: 10.3949/ccjm.84a.17024

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Renal denervation: Are we on the right path?
Ali E. Denktas, David Paniagua, Hani Jneid
Cleveland Clinic Journal of Medicine Sep 2017, 84 (9) 687-689; DOI: 10.3949/ccjm.84a.17024
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • HYPERTENSION: COMMON, OFTEN RESISTANT
    • SYMPLICITY HTN-3 TRIAL: WHAT DID WE LEARN?
    • ONGOING STUDIES
    • NOT READY FOR CLINICAL USE
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • Renal denervation: What happened, and why?
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Calcium pyrophosphate deposition and crowned dens syndrome
  • Median arcuate ligament syndrome: A clinical dilemma
  • All that wheezes…
Show more Editorial

Similar Articles

Subjects

  • Vascular Medicine
  • Nephrology
  • Cardiology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit
  • Advertise Contact

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • Advertisers
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2021 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire